Investors Hear All the Right Noises From Nuvilex Inc (PINK:NVLX)
Considering the fact that they have been promoted so many times in the past, Nuvilex Inc (PINK:NVLX)’s performance has been quite decent so far. A quick look at our database reveals that after the first campaign that we intercepted back in May 2011, we have received dozens of emails about NVLX and today, we got some more.
The list of products that NVLX have developed over the years is almost as long as the list of promoters that have been creating excitement around them. They started off back in 2003 with the intention of developing technology that is supposed to keep vegetable and fruit produce fresh for longer periods of time. Then, in 2005 they turned their attention to scar and acne reducing pharmaceuticals. When that didn’t work out, they developed products that are supposed to strengthen your immune system. Then it was the turn of the tattoo ink that is easier to remove compared to the conventional stuff.
While they were wondering what the next business direction should be, the pumpers were desperately trying to boost the awareness around their shares, but unlike some of NVLX‘s small cap counterparts, they didn’t crumble under the pressure. In fact, their price has remained relatively stable throughout the years.
This would suggest that their shareholders have quite a lot of confidence in the company and judging by the opinions posted on message boards right now, they are more supportive than ever. And NVLX‘ latest business plan is the reason for their positivism.
NVLX are actually developing a treatment for pancreatic cancer and according to their press releases and updates they are progressing along nicely. They recently also established their newest subsidiary which will be researching and developing ways in which the application of medical marijuana derived substances can help with the discovery of the pill that will someday treat one of the worst diseases mankind has ever faced.
While the support from the long-term shareholders and the relatively calm performance during pumps is something we’re not used to seeing with penny stock companies, the same can not be said about their financial statement. It looks pretty similar to what we see from other promoted penny stocks every day – huge losses, very little in terms of cash and a gigantic accumulated deficit. Here are the figures as of January 31:
- cash: $33 thousand
- current assets: $1.4 million
- current liabilities: $3.6 million
- quarterly revenue: $0
- quarterly net loss: $376 thousand
There have been no revenues during the three months that were covered in the report solely because NVLX have devoted their whole attention to the development of the cancer treatment solution, however, during the previous years, when they had other products that they were able to sell, they were still working at a loss. This means that they will really need to work hard on producing the solution at the best possible price if they want to ensure profit for both the company and the shareholders. They will also need to put in quite a lot of effort in providing the funding the development of the revolutionary pill.
And while the intentions of NVLX and the development of their cancer treatment solution are as noble as they get, things might not be all that crystal clean when it comes to the pump that is taking place as we speak. The promoters who have taken on the task of touting NVLX‘s stock this time are Stock Traders Academy, Black Tie Stock Alerts and Titan Stock Alerts. They were all part of the promotional campaign on Nano Labs Corp. f//k/a Colorado Ceramic Tile, Inc. (OTC:CTLE) from the beginning of the month, however, as you can see form the chart on the right, the effect on the stock performance was minimal until yesterday when CTLE took a 27% plunge.
In NVLX‘s report, we can see that they have issued quite a lot of shares in exchange for services and debt recently and if the people now holding these shares decide to sell them, we could see much the same movement in NVLX‘s chart really soon.
